AI-Powered Clinical Trials for Better Medical Outcomes
TrialKey stands as the market leader for clinical trial prediction and design optimization, with an accuracy rate of +90%
+90% accuracy* in predicting the possibility of success of any clinical trial
Trained using data from +350,000 historical trials and 700+ variables
Pinpoint readily addressable changes to boost the success likelihood by up to 30%.
* based on precision/recall
Drawing on an extensive dataset spanning over 20 years, TrialKey employs AI and GPT-4 to analyze real-world trial data and provide users with comprehensive insights on competitor trials, similar trials across specific therapy areas, trial design and execution optimization, and specific recommendations to improve drug mechanisms of action.
Our model delivers tailored, actionable steps to address critical trial challenges, increasing the likelihood of its success as quickly as possible and at lower costs.
How we can help you
TrialKey was created to empower patients, clinicians, and investors by providing transparency and insights for better decision-making in clinical trials.
Patients & Doctors
Explore potential treatment options and understand the likelihood of success in clinical trials in just a few clicks.
Clinical Researchers
Use AI to improve clinical trial designs through in-depth variable analysis and our clinical trial simulator.
Investors & Analysts
Use the predicted likelihood of the success of a trial along with the predicted date of completion to help inform your investment decisions.
Accuracy in clinical trials starts here.
TrialKey stands as the market leader for clinical trial prediction and design optimization, with an accuracy rate of +90%